D, StringerBraude, P.Myint, P KEvans, LCollins , J.T.Verduri , AQuinn, Terence JVilches-Moraga, A.Stechman, Michael JPearce, L.Moug, SMcCarthy, KHewitt, J.COPE Study CollaboratorsCarter, B2022-03-032022-03-032021-04D, S, Braude, P, Myint, P K, Evans, L, Collins , J T, Verduri , A, Quinn, T J, Vilches-Moraga, A, Stechman, M J, Pearce, L, Moug, S, McCarthy, K, Hewitt, J, COPE Study Collaborators & Carter, B 2021, 'The role of C-reactive protein (CRP) as a prognostic marker in COVID-19', International Journal of Epidemiology, vol. 50, no. 2, pp. 420-429. https://doi.org/10.1093/ije/dyab0120300-5771ORCID: /0000-0003-3852-6158/work/163198751https://hdl.handle.net/2164/18155Funding declaration This study received no specific funding. The study was partially supported through the NIHR Maudsley Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust in partnership with King's College London (BC)10285738engCRPCOVID-19BimodalTrimodalMortalityPrognostic markerMixture ModeR MedicineSupplementary DataRJournal article10.1093/ije/dyab012http://www.scopus.com/inward/record.url?scp=85106667177&partnerID=8YFLogxK502